In this study, hUC-MSCs exerted hepatoprotective effects by alleviating steatosis, inflammation and fibrosis in NAFLD, which was attributed to enhanced autophagy via the AMPK-mTOR-TFEB signaling axis (Fig. 8). Here, MTOR is linked to metabolic dysfunction-associated steatotic liver disease.